These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15664248)

  • 21. Differentiation of multicentric origin from intra-organ metastatic spread of hepatocellular carcinomas by comparative genomic hybridization.
    Wilkens L; Bredt M; Flemming P; Klempnauer J; Heinrich Kreipe H
    J Pathol; 2000 Sep; 192(1):43-51. PubMed ID: 10951399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma--results of 152 resected cases.
    Shirabe K; Wakiyama S; Gion T; Motomura K; Koyanagi T; Sakamoto S; Nagaie T
    Hepatogastroenterology; 2007; 54(79):2084-7. PubMed ID: 18251164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV.
    Wang J; Li Q; Sun Y; Zheng H; Cui Y; Li H; Zhou H; Hao X
    Surg Oncol; 2009 Mar; 18(1):25-30. PubMed ID: 18640032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early hepatocellular carcinoma and dysplastic nodules.
    Kojiro M; Roskams T
    Semin Liver Dis; 2005; 25(2):133-42. PubMed ID: 15918142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
    Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
    Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study.
    Grasso A; Stigliano R; Morisco F; Martines H; Quaglia A; Dhillon AP; Patch D; Davidson BR; Rolles K; Burroughs AK
    Transplantation; 2006 Jun; 81(11):1532-41. PubMed ID: 16770242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathology of early hepatocellular carcinoma: progression from early to advanced.
    Kojiro M
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1203-5. PubMed ID: 9730375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study.
    Bräu N; Fox RK; Xiao P; Marks K; Naqvi Z; Taylor LE; Trikha A; Sherman M; Sulkowski MS; Dieterich DT; Rigsby MO; Wright TL; Hernandez MD; Jain MK; Khatri GK; Sterling RK; Bonacini M; Martyn CA; Aytaman A; Llovet JM; Brown ST; Bini EJ;
    J Hepatol; 2007 Oct; 47(4):527-37. PubMed ID: 17692986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small hepatocellular carcinoma with minute satellite nodules.
    Maeda T; Takenaka K; Taguchi K; Kajiyama K; Shirabe K; Shimada M; Honda H; Sugimachi K
    Hepatogastroenterology; 2000; 47(34):1063-6. PubMed ID: 11020880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current role of surgery in treatment of early stage hepatocellular carcinoma: resection versus liver transplantation.
    Yi NJ; Suh KS; Kim T; Kim J; Shin WY; Lee KU
    Oncology; 2008; 75 Suppl 1():124-8. PubMed ID: 19092282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological diagnosis at early stage: reaching international consensus.
    Kojiro M
    Oncology; 2010 Jul; 78 Suppl 1():31-5. PubMed ID: 20616581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of incidentally found hepatocellular carcinoma on the outcome of living donor liver transplantation.
    Kishi Y; Sugawara Y; Tamura S; Kaneko J; Kokudo N; Makuuchi M
    Transpl Int; 2006 Sep; 19(9):720-5. PubMed ID: 16918532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors.
    Moucari R; Rautou PE; Cazals-Hatem D; Geara A; Bureau C; Consigny Y; Francoz C; Denninger MH; Vilgrain V; Belghiti J; Durand F; Valla D; Plessier A
    Gut; 2008 Jun; 57(6):828-35. PubMed ID: 18218675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma.
    Akiba J; Ogasawara S; Kawahara A; Nishida N; Sanada S; Moriya F; Kuwano M; Nakashima O; Yano H
    Oncol Rep; 2008 Dec; 20(6):1329-35. PubMed ID: 19020710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.